Clinical Trial Update: An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)

View source ↗

Summary

An observational study (ACT-LIFE) evaluating real-world dosage patterns in rheumatoid arthritis patients is completed, sponsored by Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED